205 related articles for article (PubMed ID: 19383845)
1. Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.
Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
Mol Cancer Ther; 2009 May; 8(5):1045-54. PubMed ID: 19383845
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance.
Humeniuk R; Menon LG; Mishra PJ; Gorlick R; Sowers R; Rode W; Pizzorno G; Cheng YC; Kemeny N; Bertino JR; Banerjee D
Mol Cancer Ther; 2009 May; 8(5):1037-44. PubMed ID: 19383847
[TBL] [Abstract][Full Text] [Related]
3. The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors.
Morita S; Iida S; Kato K; Takagi Y; Uetake H; Sugihara K
Oncology; 2006; 71(5-6):437-45. PubMed ID: 17690560
[TBL] [Abstract][Full Text] [Related]
4. Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells.
Shen Y; Tong M; Liang Q; Guo Y; Sun HQ; Zheng W; Ao L; Guo Z; She F
Pharmacogenomics J; 2018 Jan; 18(1):23-28. PubMed ID: 28045128
[TBL] [Abstract][Full Text] [Related]
5. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
Arnold CN; Goel A; Boland CR
Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
[TBL] [Abstract][Full Text] [Related]
6. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells.
Wen S; Wang X; Wang Y; Shen J; Pu J; Liang H; Chen C; Liu L; Dai P
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):896-905. PubMed ID: 29475390
[TBL] [Abstract][Full Text] [Related]
10. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells.
Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G
J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028
[TBL] [Abstract][Full Text] [Related]
12. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.
Lin K; Jiang H; Zhuang SS; Qin YS; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
FASEB J; 2019 Feb; 33(2):1972-1988. PubMed ID: 30226808
[TBL] [Abstract][Full Text] [Related]
14. Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase.
Hosokawa M; Seiki R; Iwakawa S; Ogawara KI
Biochem Biophys Res Commun; 2021 Nov; 578():157-162. PubMed ID: 34571370
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
16. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
[TBL] [Abstract][Full Text] [Related]
17. [Effects of 5-Aza-dC on 5-Fu chemosensitivity by modulating TIP30 gene expression in human colorectal cancer cells].
Chen XB; Chen BB; Li J; Wang XF; Ma YJ; Luo SX; Lü HF
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):824-7. PubMed ID: 24447479
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
19. Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity.
Edahiro K; Iimori M; Kobunai T; Morikawa-Ichinose T; Miura D; Kataoka Y; Niimi S; Wakasa T; Saeki H; Oki E; Kitao H; Maehara Y
Mol Cancer Res; 2018 Oct; 16(10):1483-1490. PubMed ID: 29866926
[TBL] [Abstract][Full Text] [Related]
20. Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells.
Zhang Q; Liu RX; Chan KW; Hu J; Zhang J; Wei L; Tan H; Yang X; Liu H
J Exp Clin Cancer Res; 2019 Jul; 38(1):320. PubMed ID: 31324203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]